These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37064469)

  • 1. Adherence to and persistence with lacosamide, perampanel, lamotrigine, and levetiracetam in adult patients with focal epilepsy in Japan: A descriptive cohort study using a claims database.
    Chen S; Fukasawa T; Ikeda A; Takeuchi M; Shimotake A; Yoshida S; Kawakami K
    Heliyon; 2023 Apr; 9(4):e15017. PubMed ID: 37064469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater need for treatment optimization in patients with epilepsy initiating adjunctive therapy: Results of a retrospective claims analysis of antiseizure medication drug load in the United States.
    Connor GS; Labiner DM; Schabert VF; Weingarten M; Wade CT; Stern S; Becker DA
    Epilepsy Behav; 2024 Mar; 152():109649. PubMed ID: 38277849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
    Terman SW; Youngerman BE; Choi H; Burke JF
    Epilepsia; 2022 Jun; 63(6):1571-1579. PubMed ID: 35294775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2022 Oct; 36(10):1079-1111. PubMed ID: 36194365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world analysis of retention on cenobamate in patients with epilepsy in the United States.
    Stern S; Weingarten M; Mandapati S; Ferrari L; Wade CT
    Epilepsy Res; 2023 Nov; 197():107207. PubMed ID: 37741165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of antiseizure medication use and cost in the United States of America 2006-2021.
    Sánchez Fernández I; Gaínza-Lein M; Amengual-Gual M; Barcia Aguilar C; Romeu A; Torres A; Jonas R; Douglass LM
    Seizure; 2023 Nov; 112():128-138. PubMed ID: 37832279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiseizure medication selection and retention for adult onset focal epilepsy in a Swedish health service region: A population-based cohort study.
    Larsson D; Mroué D; Andrén K; Zelano J
    Epilepsia; 2023 Oct; 64(10):2617-2624. PubMed ID: 37422699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Leppien EE; Doughty BJ; Hurd KL; Strong KN; Piper BJ; McCall KL
    Clin Drug Investig; 2023 Jun; 43(6):393-399. PubMed ID: 37184612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force.
    Tomson T; Battino D; Bromley R; Kochen S; Meador KJ; Pennell PB; Thomas SV
    Epileptic Disord; 2022 Dec; 24(6):1020-1032. PubMed ID: 36193017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
    Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
    Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental outcomes in children exposed to newer antiseizure medications: A systematic review.
    Knight R; Wittkowski A; Bromley RL
    Epilepsia; 2021 Aug; 62(8):1765-1779. PubMed ID: 34128227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea.
    Lee JW; Kim JA; Kim MY; Lee SK
    Epilepsy Behav; 2022 Jan; 126():108459. PubMed ID: 34902660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: A retrospective cohort study using the database of health insurance claims between 2015 and 2019.
    Jin K; Obara T; Hirano K; Hirai D; Kiuchi M; Tanaka T; Nakasato N
    Epilepsy Behav; 2022 Sep; 134():108841. PubMed ID: 35901657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world antiseizure medication treatment outcomes in drug-resistant focal epilepsy patients.
    Hatoum HT; Arcona S; Mao J; Walton S
    Epilepsia Open; 2023 Dec; 8(4):1556-1565. PubMed ID: 37842746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy.
    Barnard SN; Chen Z; Kanner AM; Holmes MG; Klein P; Abou-Khalil BW; Gidal BE; French J; Perucca P;
    Neurology; 2024 Oct; 103(7):e209821. PubMed ID: 39270150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the Use of Brand Name and Generic Medications and Total Prescription Cost Among Medicare Beneficiaries With Epilepsy.
    Terman SW; Lin CC; Kerr WT; DeLott LB; Callaghan BC; Burke JF
    Neurology; 2022 Aug; 99(8):e751-e761. PubMed ID: 35705496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical Treatment of Epilepsy].
    Jin K
    Brain Nerve; 2023 Apr; 75(4):347-351. PubMed ID: 37037506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontline Sodium Channel-Blocking Antiseizure Medicine Use Promotes Future Onset of Drug-Resistant Chronic Seizures.
    Zierath D; Mizuno S; Barker-Haliski M
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study.
    Winter Y; Sandner K; Vieth T; Gonzalez-Escamilla G; Stuckrad-Barre SV; Groppa S
    CNS Drugs; 2023 Oct; 37(10):929-936. PubMed ID: 37784006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.